Authors:
BOUNDY VA
GOLD SJ
MESSER CJ
CHEN JS
SON JH
JOH TH
NESTLER EJ
Citation: Va. Boundy et al., REGULATION OF TYROSINE-HYDROXYLASE PROMOTER ACTIVITY BY CHRONIC MORPHINE IN TH9.0-LACZ TRANSGENIC MICE, The Journal of neuroscience, 18(23), 1998, pp. 9989-9995
Citation: Va. Boundy et al., REGULATION OF CAMP-DEPENDENT PROTEIN-KINASE SUBUNIT EXPRESSION IN CATH.A AND SH-SY5Y CELLS, The Journal of pharmacology and experimental therapeutics, 286(2), 1998, pp. 1058-1065
Authors:
LANELADD SB
PINEDA J
BOUNDY VA
PFEUFFER T
KRUPINSKI J
AGHAJANIAN GK
NESTLER EJ
Citation: Sb. Laneladd et al., CREB (CAMP RESPONSE ELEMENT-BINDING PROTEIN) IN THE LOCUS-COERULEUS -BIOCHEMICAL, PHYSIOLOGICAL, AND BEHAVIORAL EVIDENCE FOR A ROLE IN OPIATE DEPENDENCE, The Journal of neuroscience, 17(20), 1997, pp. 7890-7901
Citation: Va. Boundy et al., DIFFERENTIAL COUPLING OF RAT D2 DOPAMINE-RECEPTOR ISOFORMS EXPRESSED IN SPODOPTERA-FRUGIPERDA INSECT CELLS, The Journal of pharmacology and experimental therapeutics, 276(2), 1996, pp. 784-794
Citation: Va. Boundy et al., AGONISTS AND ANTAGONISTS DIFFERENTIALLY REGULATE THE HIGH-AFFINITY STATE OF THE D2(L) RECEPTOR IN HUMAN EMBRYONIC KIDNEY 293-CELLS, Molecular pharmacology, 48(5), 1995, pp. 956-964
Authors:
BOUNDY VA
LUEDTKE RR
ARTYMYSHYN RP
FILTZ TM
MOLINOFF PB
Citation: Va. Boundy et al., DEVELOPMENT OF POLYCLONAL ANTI-D2 DOPAMINE RECEPTOR ANTIBODIES USING SEQUENCE-SPECIFIC PEPTIDES, Molecular pharmacology, 43(5), 1993, pp. 666-676
Citation: Va. Boundy et al., DEVELOPMENT OF POLYCLONAL ANTI-D2 DOPAMINE RECEPTOR ANTIBODIES TO FUSION PROTEINS - INHIBITION OF D2 RECEPTOR-G PROTEIN-INTERACTION, Journal of neurochemistry, 60(6), 1993, pp. 2181-2191
Authors:
MACH RH
LUEDTKE RR
UNSWORTH CD
BOUNDY VA
NOWAK PA
SCRIPKO JG
ELDER ST
JACKSON JR
HOFFMAN PL
EVORA PH
RAO AV
MOLINOFF PB
CHILDERS SR
EHRENKAUFER RL
Citation: Rh. Mach et al., F-18 LABELED BENZAMIDES FOR STUDYING THE DOPAMINE-D(2) RECEPTOR WITH POSITRON EMISSION TOMOGRAPHY, Journal of medicinal chemistry, 36(23), 1993, pp. 3707-3720